These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1828793)

  • 41. Influence of ofloxacin on murine Peyer's patch lymphocytes.
    De Simone C; Zanzoglu S; Santini G; Ciardi M; Delia S; Sorice F
    Infection; 1986; 14 Suppl 4():S256-7. PubMed ID: 3469157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice.
    Kunkel D; Kirchhoff D; Nishikawa S; Radbruch A; Scheffold A
    Eur J Immunol; 2003 May; 33(5):1292-301. PubMed ID: 12731054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.
    Suzuki Y; Adachi Y; Ohno N; Yadomae T
    Biol Pharm Bull; 2001 Jul; 24(7):811-9. PubMed ID: 11456123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arginine enhances induction of T helper 1 and T helper 2 cytokine synthesis by Peyer's patch alpha beta T cells and antigen-specific mucosal immune response.
    Kobayashi T; Yamamoto M; Hiroi T; McGhee J; Takeshita Y; Kiyono H
    Biosci Biotechnol Biochem; 1998 Dec; 62(12):2334-40. PubMed ID: 9972259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a]anthracene.
    Burchiel SW; Davis DA; Gomez MP; Montano RM; Barton SL; Seamer LC
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):434-42. PubMed ID: 2122550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral administration of a bacterial immunomodulator enhances murine intestinal lamina propria and Peyer's patch lymphocyte traffic to the lung: possible implications for infectious disease prophylaxis and therapy.
    Ruedl C; Albini B; Böck G; Wick G; Wolf H
    Int Immunol; 1993 Jan; 5(1):29-36. PubMed ID: 7680225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional characteristics of Peyer's patch cells. III. Carrier priming of T cells by antigen feeding.
    Kagnoff MF
    J Exp Med; 1975 Dec; 142(6):1425-35. PubMed ID: 1081580
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunologic suppression after oral administration of antigen. I. Specific suppressor cells formed in rat Peyer's patches after oral administration of sheep erythrocytes and their systemic migration.
    Mattingly JA; Waksman BH
    J Immunol; 1978 Nov; 121(5):1878-83. PubMed ID: 361892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dietary exposure to the trichothecene vomitoxin (deoxynivalenol) stimulates terminal differentiation of Peyer's patch B cells to IgA secreting plasma cells.
    Bondy GS; Pestka JJ
    Toxicol Appl Pharmacol; 1991 May; 108(3):520-30. PubMed ID: 2020973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor activity of orally administered maitake α-glucan by stimulating antitumor immune response in murine tumor.
    Masuda Y; Nakayama Y; Tanaka A; Naito K; Konishi M
    PLoS One; 2017; 12(3):e0173621. PubMed ID: 28278221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of oral tolerance in C3H/HeJ mice.
    Kiyono H; McGhee JR; Wannemuehler MJ; Michalek SM
    J Exp Med; 1982 Feb; 155(2):605-10. PubMed ID: 7035600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective induction of Th2 cells in murine Peyer's patches by oral immunization.
    Xu-Amano J; Aicher WK; Taguchi T; Kiyono H; McGhee JR
    Int Immunol; 1992 Apr; 4(4):433-45. PubMed ID: 1534253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effect of opioids on immunoglobulin production by lymphocytes isolated from Peyer's patches and spleen.
    Carr DJ; Radulescu RT; deCosta BR; Rice KC; Blalock JE
    Life Sci; 1990; 47(12):1059-69. PubMed ID: 2172675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The roles of L-selectin, beta 7 integrins, and P-selectin in leukocyte rolling and adhesion in high endothelial venules of Peyer's patches.
    Kunkel EJ; Ramos CL; Steeber DA; Müller W; Wagner N; Tedder TF; Ley K
    J Immunol; 1998 Sep; 161(5):2449-56. PubMed ID: 9725243
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Anticancer Res; 1987; 7(3 Pt B):509-12. PubMed ID: 3631910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From Peyer's patches to tonsils. Specific stimulation with ribosomal immunotherapy.
    Béné MC; Faure GC
    Drugs; 1997; 54 Suppl 1():24-8. PubMed ID: 9378075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isotype-specific immunoregulation. Evidence for a distinct subset of T contrasuppressor cells for IgA responses in murine Peyer's patches.
    Suzuki I; Kitamura K; Kiyono H; Kurita T; Green DR; McGhee JR
    J Exp Med; 1986 Aug; 164(2):501-16. PubMed ID: 2941516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of gut-associated lymphoid cells by IL-4 and B-cell growth factor II.
    Tonkonogy SL; Swain SL
    Immunology; 1988 May; 64(1):155-61. PubMed ID: 2454884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
    Suda M; Ohno N; Adachi Y; Yadomae T
    Biosci Biotechnol Biochem; 1995 Feb; 59(2):203-7. PubMed ID: 7766018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395.
    Ohno N; Yadomae T
    Carbohydr Res; 1987 Feb; 159(2):293-302. PubMed ID: 3567988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.